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Abstract 
Objective: To establish a rapid detection method for identifying rpoB mutations associated 
with rifampin (RIF) resistance in sputum specimens. 
Methods: We detected rpoB mutations directly in 90 sputum specimens collected from 
suspected tuberculosis patients using PCR-based denaturing gradient gel electrophoresis 
(DGGE) and compared these results with those obtained by rpoB sequencing and conven-
tional drug susceptibility testing.  
Results: The positive detection rate of Mycobacterium tuberculosis (M. tuberculosis) was 52.2% 
by Acid-Fast Bacilli staining and 72.2% by conventional mycobacterial culture. In contrast, the 
positive rate was significantly higher (93.3%) by PCR-based detection of the rpoB gene in the 
same specimens. Furthermore, 75% of the tested specimens presented abnormal patterns 
compared with the wild-type pattern (standard H37Rv strain) analysed by DGGE. A total of 
12 different patterns, representing 12 different rpoB mutations, were observed in the 63 
abnormal patterns. The match rate of rpoB mutations detected by DGGE reached 96.9% when 
compared to DNA sequencing. 
Conclusion:  Our  findings  indicate  that  PCR-based  DGGE  is  a  rapid  and  reliable 
bio-technique for direct detection of rpoB mutations associated with RIF resistance in the 
sputum of suspected tuberculosis patients. 
Key words: Genotyping; Mycobacterium Tuberculosis; Resistance; Microbial Drug Resistance. 
Introduction 
The most serious  threat related to tuberculosis 
control is the recent emergence of drug-resistant tu-
berculosis strains. This emergence has been induced 
by widespread use of the standard short-course drug 
regimen.  Especially  concerning  is  the  emergence  of 
multidrug-resistant  tuberculosis  (MDR-TB),  defined 
as TB that is resistant to at least isoniazid and rifam-
pin (RIF)(1-3). The re-emergence of TB worldwide and 
the rise in MDR-TB have increased demand for rapid 
and reliable drug susceptibility testing (DST) to per-
form  drug-resistance  surveillance.  Improved  testing 
would  also  aid  in  the  development  of  an  efficient 
regimen  for  appropriate  treatment  of  MDR-TB,  the 
frequency of which has gradually increased in many 
regions of the world(4, 5). Early detection of MDR-TB 
isolates is essential for efficient treatment and control 
of TB. Resistance to RIF is almost exclusively associ-
ated with mutations in the rpoB gene, which encodes 
the β-subunit of RNA polymerase in M. tuberculosis(6). 
More  than  70  distinct  rpoB  mutations  have  been 
characterised  from  RIF-resistant  M.  tuberculosis  iso-
lates  worldwide(7-11).  Approximately  95%  of 
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RIF-resistant isolates harbour mutations in the rifam-
pin resistance-determining region (RRDR), an 81-bp 
region of rpoB that spans codons 507 to 533. Mutations 
of the serine 531, histidine 526, and aspartate 516 co-
dons have been identified in approximately 86%  of 
RIF-resistant isolates. Thus, these sites represent “hot 
spots” within the RRDR(6, 12). 
Conventional, „gold standard‟ drug susceptibil-
ity  testing  of  M.  tuberculosis  is  based  on  microbial 
culture  and  is  performed  by  observation  of  either 
growth or metabolic inhibition in a medium contain-
ing anti-TB drug(s). This type of assay may take up to 
6 weeks to identify a positive culture. Furthermore, it 
has been reported that tuberculosis can be transmitted 
by  17%  of  smear-negative  and  culture-positive  M. 
tuberculosis patients (5, 13). 
Several new techniques for early detection have 
been established to shorten turnaround time and im-
prove the convenience of case management, including 
micro-hole,  micro-titre  well  methods,  the 
non-radiometric  BACTEC  960/Mycobacteria  Growth 
Indicator  Tube  method,  and  others  (14,  15).  High 
costs, technical complexity and the absence of appro-
priately trained human resources make it difficult to 
perform any of these new techniques in the countries 
where they are needed most. In addition, these new 
methods still depend on bacterial culture and suffer 
from low predictability associated with clinical irrel-
evance of the results and unacceptably low reliability 
resulting from poor reproducibility (5). 
Over  the  last  two  decades,  many  studies  have 
utilised molecular biological methods to detect rpoB 
gene mutations related to RIF-resistant M. tuberculosis 
in  various  cohorts  of  patient  samples  (7,  16,  17). 
PCR-based  denaturing  gradient  gel  electrophoresis 
(DGGE) is a simple and rapid method that has been 
widely applied to detection of mutation(s) and poly-
morphisms of various genes (18-23). This system can 
also  be  used  to  analyse  mutations  in  the rpoB  gene 
within  the  RRDR  of  M.  tuberculosis  (6,  24).  In  this 
study,  we  detected  rpoB  mutations  directly  in  the 
sputum of suspected tuberculosis patients using the 
PCR-DGGE  technique  and  compared  these  results 
with those obtained by rpoB sequencing and conven-
tional DST.  
Materials and Methods 
Sputum specimens and isolates  
A total of 90 sputum specimens were collected 
from 90 suspected tuberculosis patients diagnosed by 
experienced  pulmonologists  with  strongly  positive 
reaction to tuberculin skin test and specific signs and 
syndromes  consistent  with  tuberculosis  in  the  First 
Affiliated Hospital  of Zhejiang University from  Oc-
tober 2004 to May 2005. All patients hadn‟t received 
any  anti-TB  treatment.  The  standard  M. tuberculosis 
isolate  H37Rv  was  purchased  from  the  Shanghai 
Centre  for  Disease  Control  and  Prevention,  China. 
Informed consent was obtained from all patients to 
utilise  their  sputum  specimens  for  this  study.  All 
specimens were tested by conventional M. tuberculosis 
culture. Before culture, the sputum specimens were 
digested  and  decontaminated  by  the 
N-acetyl-L-cysteine (NALC)-NaOH  to prevent over-
growth of the culture by nonmycobacterial microor-
ganisms. Two volumes of NALC-NaOH solution (4% 
NaOH,  1.45%  Na-citrate,  0.5%  NALC)  were  mixed 
with the each sputum  specimen  on a  sterilized test 
tube for digestion. The mixture was cultured at room 
temperature for 15 minutes with a gentle shaking. Ten 
volumes of 6.7 mM phosphate buffer solution (PBS, 
pH 7.4) were added and the mixture centrifuged at 
3,000  x  g  for  15  minutes  at  room  temperature.  The 
supernatant  was  discarded  and  the  pellet  washed 
twice with PBS. Then the pellet was resuspended with 
0.5 ml of PBS. A 100 µl aliquot of the suspension was 
directly processed for M. tuberculosis culture, and the 
remainder  used  for  Acid-Fast  Bacilli  (AFB)  staining 
and  PCR.  M.  tuberculosis  culture  were  used  by  the 
conventional Lowensein-Jensen (LJ) medium at 37°C 
in 5% CO 2 for 1 week, at 37°C in air for another 7 
weeks and thereafter were observed once a week for 
M.  tuberculosis  growth.  The  fresh  growth  was  then 
subcultured  onto  LJ  medium  for  DST.  DST  for  re-
sistance to the first-line drugs RIF (40 µg/ml), INH 
(0.2 µg/ml), ethambutol (EMB, 2 µg/ ml) and strep-
tomycin (STR, 4 µg/ ml)  using the agar proportion 
method as previously described (25). In brief, growth 
from the primary isolation medium was subcultured 
onto LJ medium. Bacterial inoculation was performed 
by  picking  fresh  colonies  from  the  LJ  medium  and 
adjusting  cultures  to  a  turbidity  matching  that  of  a 
McFarland 1 standard. A 100 µl aliquot of 100- and 
10,000-fold  dilution  samples  were  plated  onto 
drug-containing and no-drug sectors of Middlebrook 
7H10  quadrant  plates.  All  inoculations  were  incu-
bated at 37ºC in 5% CO2 for 8 weeks. Resistance to the 
drugs was defined as >1% growth in drug-containing 
medium compared to growth in the drug-free control 
medium (American National Committee for Clinical 
Laboratory  Standards,  NCCLS,  1995).  Isolates  re-
sistant  to  at  least  RIF  and  INH  were  classified  as 
MDR-TB.  
Acid-fast bacilli staining and DNA extraction 
All 90 sputum specimens were smeared for AFB 
staining. A 100 µl aliquot of the decontaminated spu-Int. J. Med. Sci. 2012, 9 
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tum specimen was spread onto a slide over an area of 
1-2 cm, air-dried, and heat fixed. Smeared specimens 
were inactivated using 5% phenol in ethanol for 5 min 
before they were moved from the biosafety cabinet to 
the staining sink. Smear staining was performed as 
previously described (26). Extraction of M. tuberculosis 
DNA from all 90 decontaminated sputum specimens 
was performed using a QIAamp DNA mini kit (Qi-
agen, CA, USA) as previously described (27). Briefly, 
A  100  µl  aliquot  of  the  decontaminated  sputum 
specimen was mixed with an equal volume of deion-
ised water and centrifuged for 10 min at 14,000 x g. 
The pellet was resuspended in ATL buffer (Qiagen, 
CA, USA) containing 1 mg/ml proteinase K and in-
cubated at 56 °C for 60 min. Subsequently, two cycles 
of freeze-thawing were performed to lyse the myco-
bacterial cells. DNA was then purified and collected 
for PCR detection. The standard M. tuberculosis H37Rv 
isolates  and  normal  human-derived  sputum  were 
cultured as positive and negative controls and DNA 
was  extracted  from  these  samples  using  the  same 
protocol. DNA extraction and PCR amplification were 
carried out in a specific PCR diagnosis room to pre-
vent cross-contamination of nucleic acids. 
PCR amplification 
The  126-bp  partial  sequence  of  the  rpoB  gene 
(GenBank accession no. L27989), including the RRDR 
(an 81-bp region within the  rpoB gene that encodes 
residues 507 to 533), was amplified by PCR from all 
sputum  specimens  with  forward 
(5‟-CGCCGCGATCAAGGAGTTCT-3‟)  and  reverse 
(5‟-  TCACGTGACAGACCGCCGGG-3‟)  primers 
purchased from Shanghai Sangon Company (Sangon, 
Shanghai,  China).  These  primers  specifically  ampli-
fied M. tuberculosis sequences and did not cross-react 
with non-tuberculosis mycobacterial sequences. PCR 
reactions were performed according to the manufac-
turer‟s  technical  instructions  (Invitrogen,  NY,  USA) 
and  our  previously  described  methods  (7).  Briefly, 
PCR reactions were carried out in 50 μl total volume, 
containing 1×PCR reaction buffer, 200 µM dNTPs, 1U 
of Taq polymerase, 20 pmoles of each primer, and 2 µl 
of the DNA sample. The reaction mixtures were then 
subjected to one cycle of 94°C for 2 min, followed by 
35 cycles of 94°C for 45 s, 55°C for 45 s, 72°C for 30 s, 
and a final cycle of 72°C for 7 min to complete elon-
gation of the intermediate PCR products. PCR prod-
ucts (5 µl) were analysed by electrophoresis through 
1.5%  agarose  gels  and  ethidium  bromide  staining. 
Each sample was tested in triplicate and the standard 
M. tuberculosis H37Rv isolate was used as a positive 
control. The presence of a 126-bp band on the agarose 
gel indicated successful amplification. 
PCR-DGGE  
PCR-based  DGGE  analysis  was  carried  out  to 
rapidly  detect  rpoB  gene  mutations  from  the  90 
specimens, followed by subsequent confirmation by 
conventional DST and DNA sequencing. The method 
employed was modified from Scarpellini, P. et al. (24) 
and McCammon, M. T. et al. (6). Briefly, 15 µl of the 
PCR products were loaded onto a 15% acrylamide gel 
in 1× TAE buffer. The denaturing gradient consisted 
of 50% to 80% denaturant (100% denaturant is 40% 
formamide and 7 M urea in 1× TAE buffer) at a con-
stant temperature of 60°C at 120 V for 4 hours. Gels 
were stained with SYBR GREEN I (Dingguo Biotech-
nology, Beijing, China) for 15 min and photographed 
on a UV transilluminator. The standard M. tuberculosis 
H37Rv isolate was used as a wild-type pattern con-
trol. The DGGE gel images were analysed using the 
BioNumerics software version 5.1. Position tolerance 
for band matching was set at 1% to help correct for 
slight  migratory  variation.  Migratory  distance  for 
each band was determined by the BioNumerics soft-
ware. Similarity matrix and dendrogram of the DGGE 
profiles were generated on the base of Pearson corre-
lation coefficient. 
DNA sequencing 
PCR products were purified using a QIAquick 
gel  extraction  kit  (Qiagen,  CA,  USA)  followed  by 
electrophoresis  on  1.5%  agarose  gels.  Five  hundred 
nanograms  of  the  purified  PCR  products  were  se-
quenced by the Shanghai Sangon Company (Sangon, 
Shanghai, China) on an ABI 373 automated sequencer 
(Applied Biosystems, CA, USA). The sequence data 
were analysed using the Sequencer program, version 
3.0. DNAssist version 1.02 was used to compare the 
sequences  with  the  H37Rv  genome  database  (Gen-
Bank accession no. L27989). 
Statistical analysis 
Data were evaluated using the chi-squared test 
for five different detection methods (Table 2) using 
the SPSS software, version 16.0. The level of signifi-
cance for all statistical analyses was P < 0.05. 
Results 
AFB staining and drug susceptibility testing 
Results of the AFB staining and DST for the M. 
tuberculosis  samples  tested  are  shown  in  Table  1. 
Overall, 52.2% (47/90) of the specimens from poten-
tial tuberculosis patients were classified as positive for 
M. tuberculosis by AFB staining. And the conventional 
term culture showed 72.2% (65/90) of sputum sam-
ples were positive for M. tuberculosis. The Subsequent Int. J. Med. Sci. 2012, 9 
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results  of  DST  showed  that  11  strains  were  single 
RIF-resistant strains (8 from AFB-positive and 3 from 
AFB-negative specimens)  and 35 were MDR strains 
(29  from  AFB-positive  and  6  from  AFB-negative 
specimens). Moreover, we identified 9 strains (6 from 
AFB-positive  and  3  from  AFB-negative  specimens) 
that were susceptible to RIF but resistant to any of the 
other three anti-TB drugs (INH, EMB and STR) and 10 
strains that were susceptible to all four anti-TB drugs 
(4  from  AFB-positive  and  6  from  AFB-negative 
specimens).  
 
Table 1. Detection of rpoB mutations from sputum samples by five different techniques.  
Analysis Method  AFB-Positive  
n1=47  
AFB-Negative 
n2=43  
Total Percentage 
(%) 
AFB  47  43  47/90 (52.2) 
CMC  47  18  65/90 (72.2) 
DST  R-RIF  8  3  11 
MDR  29  6  35 
R-I/E/S  6  3  9 
S-R/I/E/S  4  6  10 
rpoB-PCR  47  37   84/90 (93.3) * 
rpoB-DGGE  37  26  63/84 (75.0) 
rpoB-DNA Sequencing  38  27  65/84 (77.4)  
AFB: AFB smear, CMC: conventional mycobacterial culture, R-RIF: mono-resistance to rifampin, MDR: multidrug-resistant, R-I/E/S: re-
sistance to isoniazid, ethambutol or streptomycin, S-R/I/E/S: susceptible to rifampin, isoniazid, ethambutol and streptomycin.  
*: p < 0.05 compared to the AFB smear (52.2%) and CMC (72.2%). 
 
 
Table 2. Genetic alterations of the rpoB gene in 90 sputum specimens collected from suspected tuberculosis patients. 
Mutation 
codon 
DAN sequencing  DST  Frequency (%) of 
mutation 
n=84* 
PCR-DGGE 
positive (No.) 
n=84*  Positive  Negative 
Mutation  Amino acid 
change 
R-RIF  MDR  R-I/E/S  S-R/I/E/S 
533  CTG→TTG  Leu→Leu          2  2(2.4)  2 
531  TCG→TTG  Ser→Leu  2  2      1
Δ  9(10.7)  8 
TCG→TGG  Ser→Trp    2      2     
526  CAC→GAC  His→Asp  5  22      5  43(51.2)  42 
CAC→TAC  His→Tyr  2  7      1
Δ     
CAC→CTT  His→Leu  1             
521  CTG→TTG  Leu→Leu      1      1 (1.2)  1 
519  AAC→GAC  Asn→Asp      1      1 (1.2)  1 
518  AAC→GAC  Asn→Asp      1      1 (1.2)  1 
516  GAC→GGA  Asp→Gly      1    2  5 (6.0)  5 
GAC→TAC  Asp→Tyr          2     
513  CAA→GAA  Gln→Glu  1  2        3(3.6)  3 
Total mutation (%)  50    15  65 (77.4)  63(75.0) 
No Mutation      5  10  4     
R-RIF: mono-resistance to rifampin; MDR: multidrug-resistant; R-I/E/S: resistance to isoniazid, ethambutol or streptomycin, S-R/I/E/S: 
susceptible to rifampin, isoniazid, ethambutol and streptomycin 
*: Total of 84 rpoB-PCR positive specimens. 
Δ: The specimens harboured rpoB mutations but present wild-type-like DGGE patterns. Int. J. Med. Sci. 2012, 9 
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PCR and DNA sequencing 
The  PCR  results  (Figure  1)  showed  that  93.3% 
(84/90)  of  sputum  specimens  were  positive  for  the 
rpoB  gene;  these  samples  included  47  AFB-positive 
and 37 AFB-negative specimens. The results of sub-
sequent  DNA  sequencing  (Tables  1  and  2)  of  84 
rpoB-positive PCR products, including samples from 
38  AFB-positive  and  27  AFB-negative  specimens, 
showed that 65 specimens displayed mutations in the 
rpoB gene. Our analysis detected a total of 12 mutated 
positions  distributed  among  8  codons  within  the 
RRDR  of  the  rpoB  gene.  In  total,  61  specimens  dis-
played substitutions and 4 specimens displayed dou-
ble substitutions (3 at codon 516/GAC → GGA, 1 at 
526/CAC → CTT). The most frequent position for a 
mutation was codon 526 (51.2%, 43/84), followed by 
codon 531 (10.7%, 9/84) and codon 516 (6.0%, 5/84). 
Eight resistance-associated mutations in the rpoB gene 
occurred at codons 513 (3 specimens),  518 (1 speci-
men), 519 (1 specimen), 521 (1 specimen), and 533 (2 
specimens). Mutations at codon 526 of CAC → GAC 
(His → Asp) occurred in 32 specimens and the CAC 
→  TAC  (His  →  Tyr)  substitution  occurred  in  10 
specimens, while the CAC → CTT (His → Leu) muta-
tion occurred in only one specimen. Mutations at co-
don 531 of TCG → TTG (Ser → Leu) occurred in 5 
specimens, and a change of TCG → TGG (Ser → Trp) 
occurred in 4 specimens. The GAC → GGA (Asp → 
Gly) mutation at codon 516 occurred in 3 specimens 
and the GAC → TAC (Asp → Tyr) substitution was 
observed in 2 specimens. Comparison of these data 
with the results of conventional DST (showed in Table 
2) indicated that 11 of the RIF-resistant specimens and 
35 of the MDR-TB specimens harboured mutations at 
codons 513, 526 or 531. Four specimens susceptible to 
RIF but resistant to any one of the other three anti-TB 
drugs (isoniazid, ethambutol and streptomycin) har-
boured  mutations  at  codons  516,  518,  519  and  521. 
Fifteen specimens that displayed mutations at codons 
516  (4  specimens),  526  (6  specimens),  531  (3  speci-
mens), and 533 (2 specimens) were classified as nega-
tive by DST. 
 
 
Figure 1. The results of PCR detection. M: DNA marker, 1-90: numbered sputum specimens, PC: positive control (standard H37Rv 
strain), NC: negative control (normal human sputum). From a total of 90 sputum specimens tested, 84 were positive and 6 (No. 4, 7, 23, 
25, 37 and 67) were negative for detection of the rpoB gene. The brightness of the PCR bands was determined by the concentration of M. 
tuberculosis. 
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Figure 2. The results of the DGGE analysis. A is the DGGE profile 
of rpoB RRDR mutations for 12 different mutations. The WT lane 
is the control wild-type strain H37Rv. The following lanes are 
various sputum specimens. B is the result of DGGE analysis using 
BioNumerics software version 5.1. †: the number of specimens 
(including 2 lanes of wild-type strain H37Rv; each specimen lane is 
the same as in image A), ‡: rpoB mutation codon. Lane 36, with a 
mutation at codon 519, represents 1 specimen; lanes 7 and 11, 
with mutations at codon 516 (a, GAC→GGA, b, GAC→TAC), 
represent 2 specimens; lanes 3 and 23, with mutations at codons 
513 and 518, represent 3 and 1 specimens, respectively; lane 56, 
with a mutation at codon 526 (b, CAC→TAC), represents 11 
specimens;  lane  78,  with  a  mutation  at  codon  531  (b, 
TCG→TGG), represents 2 specimens; lane 62, with a mutation at 
codon 526 (a, CAC→GAC), represents 33 specimens; lane 88, 
with a mutation at codon 533, represents 1 specimen; lane 50, 
with  a  mutation  at  codon  526  (c,  CAC→CTT),  represents  1 
specimen; lane WT, wild-type strain H37Rv, no mutation; lane 84, 
with  a  mutation  at  codon  531  (a,  TCG→TTG),  represents  5 
specimens; lane 49, with a mutation at codon 521, represents 1 
specimen. 
 
PCR-DGGE analysis 
A total of 84 amplified rpoB-PCR products, gen-
erated from 90 sputum specimens, 126 bp in length 
were analysed by DGGE. The DGGE profile results 
(Table 2) showed that 25% (21/84) of the specimens 
displayed  the  same  (wild-type)  patterns  and  75% 
(63/84)  were  abnormal  compared  to  the  control 
wild-type pattern obtained from the fully susceptible 
standard M. tuberculosis H37Rv isolate. A total of 50 
specimens with abnormal DGGE patterns were also 
DST-positive. These included 11 specimens resistant 
to RIF, 35 specimens that were MDR and 4 specimens 
susceptible to RIF but resistant to any one of the other 
three  first-line  anti-TB  drugs.  When  we  combined 
these results with the DNA sequencing data, we de-
termined that 42 of the 63 specimens with abnormal 
patterns  harboured  mutations  at  codon  526,  8  dis-
played mutations at codon 531, 5 samples contained 
mutations at codon 516, 3 displayed mutations at co-
don 513 and 2 specimens contained mutations at co-
don 533; the remaining 3 specimens contained muta-
tions at codons 521, 519 and 518. The results of a Bi-
oNumerics analysis (Figure 2B) showed that 12 dif-
ferent  DGGE  patterns  (typical  specimens  shown  in 
Figure  2A)  were  observed  in  the  63  abnormal  pat-
terns. Each mutation generated a specific DGGE pat-
tern that was dependent on the nucleotide alterations 
and/or the position of the mutations within the RRDR 
of  the  rpoB  gene.  The  BioNumerics  analysis  also 
showed that the Pearson Correlation between 2 lanes 
of wild-type strain H37Rv (WT) reached 96.4%. The 
Pearson Correlation was 93.6% between the WT lane 
and lane 50 (mutation at codon 526); 91.3% between 
the WT lane and lane 88 (mutation at codon 533); and 
less than 85% between the WT lane and the remaining 
lanes. The DGGE method identified 96.9% of the same 
rpoB mutations as the DNA sequencing method (63 
specimens  with  abnormal  DGGE  patterns  and  65 
specimens containing mutations). 
Discussion 
Resistance to RIF is almost exclusively associated 
with  mutation of the  rpoB gene, which encodes  the 
β-subunit of RNA polymerase (28-30). More than 95% 
of  rpoB  mutations  in  RIF-resistant  clinical  isolates 
have been found within the RRDR. Over 70 distinct 
rpoB mutations and four frequent mutations (codons 
526,  513,  531  and  516)  have  been  reported  for 
RIF-resistant  M.  tuberculosis  isolates  worldwide  (31, 
32). However, it can take 6 weeks or longer to detect 
RIF resistance in M. tuberculosis by conventional cul-
ture-based  DST.  Recently,  more  rapid  and  accurate 
biomolecular techniques have received increased at-
tention as alternatives to DST (33, 34) and have been Int. J. Med. Sci. 2012, 9 
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reported  to  detect  rpoB  gene  mutations  linked  to 
RIF-resistant  M. tuberculosis (14,  15).  Kim et al.  (16) 
used  a  method  of  polymerase  chain  reaction  re-
striction analysis to analyse the rpoB gene for direct 
characterisation  of  non-tuberculous  mycobacteria  in 
AFB  smear-positive  respiratory  specimens.  The  re-
sults of O‟Riordan et al. (35) revealed that rpoB muta-
tion molecular resistance testing has the potential to 
rapidly identify MDR-TB patients and would enable 
initiation of appropriate therapy significantly earlier 
than  would  be  possible  using  conventional  testing 
methods.  Our  previous  study  revealed  that 
PCR-based single strand conformation polymorphism 
analysis (PCR-SSCP) is a rapid and useful molecular 
resistance  screening  approach  for  detection  of 
MDR-TB  (7).  DGGE  can  distinguish  mutant  ampli-
cons  from  their  wild-type  equivalents  based  on  the 
altered  melting  temperatures  of  the  mutants  as  the 
DNA fragments migrate through a gradient of dena-
turants  (6,  24,  36,  37).  McCammon  et  al.  (6)  used 
DGGE combined with DNA sequencing to detect rpoB 
and  pncA  mutations  in  RIF-  and  pyra-
zinamide-resistant  M. tuberculosis  isolates  after  con-
ventional culture and DST. Their results demonstrat-
ed the power and usefulness of DGGE in detecting 
mutations associated with drug resistance in  M. tu-
berculosis;  DGGE  is  even  more  sensitive  than  DNA 
sequencing in detecting mutations in complex DNA 
samples. In addition, DGGE can detect point muta-
tions, small insertions, and deletions. Although Scar-
pellini et al. (24) and Hori et al. (22) ever used DGGE to 
detect rpoB mutations in DST positive specimens, as 
far  as  we  are  aware,  investigators  have  not  yet  re-
ported on using DGGE to detect rpoB mutations in the 
sputum of suspected tuberculosis patients. 
In this study, PCR-based DGGE was performed 
to probe for rpoB mutations associated with RIF re-
sistance in 90 sputum specimens collected from sus-
pected  tuberculosis  patients  in  Eastern  China.  The 
results of our study indicate that the positive rate of 
detection of M. tuberculosis is only 52.2% for detection 
by AFB staining and 72.2% by conventional mycobac-
terial culture. In contrast, the positive rate of  M. tu-
berculosis detection reached 93.3% for PCR detection 
of  the  rpoB  gene  in  the  same  specimens,  which  in-
cluded 47 AFB-positive and 37 AFB-negative sputum 
samples. The positive rate of M. tuberculosis detection 
by  PCR  was  significantly  higher  than  the  rates  ob-
tained  with  AFB  staining  or  DST  (p  <  0.05).  The 
PCR-based  DGGE  results  demonstrated  that  75% 
(63/84) of specimens presented a total of 12 DGGE 
different  patterns  that  differed  from  the  wild-type 
pattern.  The  rate  of  agreement  in  detection  of  rpoB 
mutations  between  DNA  sequencing  and  DGGE 
reached 96.9%. Comprehensive analysis also revealed 
that 50 of the specimens with abnormal DGGE pat-
terns  were  validated  as  DST-positive,  including  46 
RIF-resistant  samples  (or  MDR)  and  4  specimens 
susceptible to RIF but resistant to any one of the other 
three first-line anti-TB drugs. The other 13 specimens 
have not been tested by DST but have been analysed 
by PCR-based DGGE (15 positive by PCR-based DNA 
sequencing).  Of  these  13  specimens,  7  harboured 
mutations at codon 526, 4 contained mutations at co-
don  516  and  2  displayed  alterations  at  codon  533. 
Many reports have demonstrated that M. tuberculosis 
isolates containing rpoB mutations at codons 526 and 
516 are always resistant to RIF (31, 32, 38). According 
to  this  assumption,  at  least  11  of  the  13  specimens 
with  abnormal  DGGE  patterns  were  possibly 
RIF-resistant. This assumption may also help to ex-
plain why 3 specimens that harboured rpoB mutations 
at  codons  521,  519,  and  518  presented  abnormal 
DGGE patterns but were susceptible to RIF. However, 
the mechanism of this phenomenon is unclear. Inter-
estingly, we observed that one strain with a mutation 
at  codon  516  was  susceptible  to  RIF.  Together,  our 
results indicate that PCR-based DGGE is more sensi-
tive than AFB and faster than DST (a couple of days 
vs.  6-8  weeks)  in  detecting  M.  tuberculosis  isolates. 
Therefore, the technique of DGGE analysis can rea-
sonably be considered an alternative to other indirect 
techniques of rpoB mutation in RRDR. Its compara-
tive reproducibility, together with the fact that it is 
fast and easy to complete, means that it can be used in 
clinical detection. 
In conclusion, as a rapid and valid bio-technique, 
DGGE  has  a  number  of  practical  advantages  com-
pared to other methods. It is less laborious than the 
manual  single-strand  conformation  polymorphism 
(SSCP) method used in our previous study (7) because 
it does not require the casting of ultrathin gels or the 
use  of  radioactive  isotopes.  Furthermore,  compared 
with the conventional culture system, DGGE is per-
formed  with  a  relatively  inexpensive  machine  and 
lower cost of the molecular commercial kits (BACTEC 
960 system, US$ 38,000 plus reagents and drugs cost 
per test US$ 12; DGGE system, US$ 3,500 plus rea-
gents cost per test US$ 10) used for the rpoB mutation 
analysis that allows for controlled experimental con-
ditions  and  optimum  reproducibility.  Although 
DGGE is not a novel molecular technique, our results 
and other studies have demonstrated that it is a rapid 
and valid bio-technique for early and fast detection of 
rpoB  gene  mutations  associated  with  rifampin  re-
sistance in the sputum of suspected tuberculosis pa-
tients. These findings will be aid in generating a novel Int. J. Med. Sci. 2012, 9 
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and  rapid  drug  resistance  screening  approach  for 
treatment of MDR-TB. 
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